Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
BCMA CAR-T is an established treatment approach in relapsed/refractory multiple myeloma, targeting the BCMA antigen on myeloma cells, and the two widely used approved products are idecabtagene vicleucel and ciltacabtagene autoleucel.
see also:
Adoptive T Cell Therapy / CAR-T & Multiple Myeloma (MM) / Plasmocytoma
Multiple Myeloma (MM) / Plasmocytoma & Drugs/Treatments
…